Review the March 2022 notable drug approvals.
Epsolay is a topical cream that utilizes a patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.
Vyne Therapeutics announced the availability of Zilxi (minocycline) topical foam 1.5% for the treatment of inflammatory lesions of rosacea in adults.
Epsolay is an investigational topical cream that utilizes the Company’s patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.
Foamix Pharmaceuticals has submitted a New Drug Application (NDA) for FMX103, an investigational treatment for moderate to severe papulopustular rosacea in patients ≥18 years old. FMX103 is a topical foam formulation of minocycline. The NDA submission includes data from two phase 3 trials in which the efficacy and safety of the minocycline foam 1.5% was…
Combination of ivermectin cream, doxycycline modified-release capsules has faster onset of action
Participants who responded to a question related to rosacea diagnosis in 2005 were included in the final analysis (N=82,737).